Ozanimod
Product Detail
Product Tags
| Pack Size | Availability | Price (USD) |
| 1g | In Stock | 200 |
| 5g | In Stock | 800 |
| 10g | In Stock | 1200 |
| More Sizes | Get Quotes | Get Quotes |
Chemical Name:
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
SMILES Code:
N#CC1=CC(C2=NC(C3=CC=CC4=C3CC[C@@H]4NCCO)=NO2)=CC=C1OC(C)C
InChi Code:
InChI=1S/C23H24N4O3/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3/t20-/m0/s1
InChi Key:
XRVDGNKRPOAQTN-FQEVSTJZSA-N
Keyword:
Ozanimod, RPC-1063, RPC1063, RPC 1063, 1306760-87-1
Solubility: Soluble in DMSO
Storage: 0 - 4°C for short term (days to weeks), or -20°C for long term (months).
Description:
Ozanimod is a selective, orally available modulator of the sphingosine-1-phosphate (S1P) receptors S1P1 and SIP5. It induces internalization of S1P1, decreases circulating B and CCR7(+) T lymphocytes, and reduces inflammation and disease parameters in three autoimmune disease models.1 Ozanimod is in clinical trials for relapsing multiple sclerosis and ulcerative colitis.
Target: S1P
